Non-clinical Statistics in Drug Discovery
Kimberly Crimin (Novartis, Cambridge, Massachusetts, USA),Thomas J. Vidmar (Pfizer, Kalamazoo, Michigan, USA)
Non-clinical Statistics in Drug Discovery
Kimberly Crimin (Novartis, Cambridge, Massachusetts, USA),Thomas J. Vidmar (Pfizer, Kalamazoo, Michigan, USA)
It is critical for non-clinical statisticians to communicate effectively with scientists. Therefore, they must possess the ability to transform scientific questions into statistical hypotheses and models. This book affords both new and experienced statisticians with the opportunity to enhance their statistical tools and improve their consulting skills. It begins by discussing the consulting role of the statistician in drug discovery. It then proceeds to discuss the scientific questions, statistical hypotheses and methodologies, and meaningful tabular and graphical displays used in high-throughput screening, lead-finding animal experiments, drug safety, pharmaceutical science, chemometrics, and genomics.
Order online and we’ll ship when available (15 July 2025)
Our stock data is updated periodically, and availability may change throughout the day for in-demand items. Please call the relevant shop for the most current stock information. Prices are subject to change without notice.
Sign in or become a Readings Member to add this title to a wishlist.